<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23509286</PMID><DateCompleted><Year>2013</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>14</Issue><PubDate><Year>2013</Year><Month>Apr</Month><Day>02</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Structure of human enterovirus 71 in complex with a capsid-binding inhibitor.</ArticleTitle><Pagination><StartPage>5463</StartPage><EndPage>5467</EndPage><MedlinePgn>5463-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1222379110</ELocationID><Abstract><AbstractText>Human enterovirus 71 is a picornavirus causing hand, foot, and mouth disease that may progress to fatal encephalitis in infants and small children. As of now, no cure is available for enterovirus 71 infections. Small molecule inhibitors binding into a hydrophobic pocket within capsid viral protein 1 were previously shown to effectively limit infectivity of many picornaviruses. Here we report a 3.2-&#xc5;-resolution X-ray structure of the enterovirus 71 virion complexed with the capsid-binding inhibitor WIN 51711. The inhibitor replaced the natural pocket factor within the viral protein 1 pocket without inducing any detectable rearrangements in the structure of the capsid. Furthermore, we show that the compound stabilizes enterovirus 71 virions and limits its infectivity, probably through restricting dynamics of the capsid necessary for genome release. Thus, our results provide a structural basis for development of antienterovirus 71 capsid-binding drugs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Plevka</LastName><ForeName>Pavel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Purdue University, West Lafayette, IN 47907-2032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>Rushika</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Yap</LastName><ForeName>Moh Lan</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Cardosa</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kuhn</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Rossmann</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>3ZFE</AccessionNumber><AccessionNumber>3ZFF</AccessionNumber><AccessionNumber>3ZFG</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI011219</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR025761</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 RR007707</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RR007707</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AI011219</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RR025761</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI11219</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007555">Isoxazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>FX8Q9PI4VP</RegistryNumber><NameOfSubstance UI="C045978">disoxaril</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003460" MajorTopicYN="N">Crystallization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007555" MajorTopicYN="N">Isoxazoles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="Y">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="Y">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014961" MajorTopicYN="N">X-Ray Diffraction</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23509286</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pii">1222379110</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chan LG, et al. For the Outbreak Study Group Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin Infect Dis. 2000;31(3):678&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JP, Jr, Baden L, Pallansch MA, Anderson LJ. Enterovirus 71 infections and neurologic disease&#x2014;United States, 1977-1991. J Infect Dis. 1994;169(4):905&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann MG, et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature. 1985;317(6033):145&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">2993920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann MG. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance. J Biol Chem. 1989;264(25):14587&#x2013;14590.</Citation><ArticleIdList><ArticleId IdType="pubmed">2670920</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. Crystal structure of human enterovirus 71. Science. 2012;336(6086):1274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol. 2012;19(4):424&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Belnap DM, et al. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci USA. 2000;97(1):73&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26618</ArticleId><ArticleId IdType="pubmed">10618373</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonno RJ, et al. Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc Natl Acad Sci USA. 1988;85(15):5449&#x2013;5453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC281774</ArticleId><ArticleId IdType="pubmed">2840661</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson NH, et al. Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci USA. 1993;90(2):507&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC45692</ArticleId><ArticleId IdType="pubmed">8093643</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, et al. Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci USA. 2000;97(1):79&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26619</ArticleId><ArticleId IdType="pubmed">10618374</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, et al. Complexes of poliovirus serotypes with their common cellular receptor, CD155. J Virol. 2003;77(8):4827&#x2013;4835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC152153</ArticleId><ArticleId IdType="pubmed">12663789</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, et al. Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses. Proc Natl Acad Sci USA. 2008;105(47):18284&#x2013;18289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2587566</ArticleId><ArticleId IdType="pubmed">19011098</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing L, et al. Distinct cellular receptor interactions in poliovirus and rhinoviruses. EMBO J. 2000;19(6):1207&#x2013;1216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC305662</ArticleId><ArticleId IdType="pubmed">10716921</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann MG. Viral cell recognition and entry. Protein Sci. 1994;3(10):1712&#x2013;1725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2142612</ArticleId><ArticleId IdType="pubmed">7849588</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth M, Pettitt T, Symonds A, Martin J. Identification of the pocket factors in a picornavirus. Arch Virol. 2003;148(6):1225&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">12756627</ArticleId></ArticleIdList></Reference><Reference><Citation>Filman DJ, et al. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 1989;8(5):1567&#x2013;1579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC400988</ArticleId><ArticleId IdType="pubmed">2548847</ArticleId></ArticleIdList></Reference><Reference><Citation>Muckelbauer JK, et al. The structure of coxsackievirus B3 at 3.5 &#xc5; resolution. Structure. 1995;3(7):653&#x2013;667.</Citation><ArticleIdList><ArticleId IdType="pubmed">8591043</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer F, et al. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci USA. 1994;91(5):1839&#x2013;1842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC43259</ArticleId><ArticleId IdType="pubmed">8127891</ArticleId></ArticleIdList></Reference><Reference><Citation>Querol-Aud&#xed; J, et al. Minor group human rhinovirus-receptor interactions: Geometry of multimodular attachment and basis of recognition. FEBS Lett. 2009;583(1):235&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">19073182</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarkson NA, et al. Characterization of the echovirus 7 receptor: Domains of CD55 critical for virus binding. J Virol. 1995;69(9):5497&#x2013;5501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189399</ArticleId><ArticleId IdType="pubmed">7543583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lea SM, et al. Determination of the affinity and kinetic constants for the interaction between the human virus echovirus 11 and its cellular receptor, CD55. J Biol Chem. 1998;273(46):30443&#x2013;30447.</Citation><ArticleIdList><ArticleId IdType="pubmed">9804811</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J. 2009;6:141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamura K, Nishimura Y, Abo M, Wakita T, Shimizu H. Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J Gen Virol. 2011;92(Pt 2):287&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3081077</ArticleId><ArticleId IdType="pubmed">20943886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, et al. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Wakita T, Shimizu H. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 2010;6(11):e1001174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2973824</ArticleId><ArticleId IdType="pubmed">21079683</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann MG, He Y, Kuhn RJ. Picornavirus-receptor interactions. Trends Microbiol. 2002;10(7):324&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">12110211</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao R, et al. Human rhinovirus 3 at 3.0 &#xc5; resolution. Structure. 1996;4(10):1205&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pubmed">8939746</ArticleId></ArticleIdList></Reference><Reference><Citation>Katpally U, Smith TJ. Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus. J Virol. 2007;81(12):6307&#x2013;6315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1900100</ArticleId><ArticleId IdType="pubmed">17428846</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant RA, et al. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr Biol. 1994;4(9):784&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">7820548</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TJ, et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 1986;233(4770):1286&#x2013;1293.</Citation><ArticleIdList><ArticleId IdType="pubmed">3018924</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman MS, Rossmann MG. Comparison of surface properties of picornaviruses: Strategies for hiding the receptor site from immune surveillance. Virology. 1993;195(2):745&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">8337843</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C, et al. The crystal structure of coxsackievirus A21 and its interaction with ICAM-1. Structure. 2005;13(7):1019&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">16004874</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CS, et al. Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives. J Med Chem. 2005;48(10):3522&#x2013;3535.</Citation><ArticleIdList><ArticleId IdType="pubmed">15887961</ArticleId></ArticleIdList></Reference><Reference><Citation>Shia KS, et al. Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: A novel class of potent and selective human enterovirus 71 inhibitors. J Med Chem. 2002;45(8):1644&#x2013;1655.</Citation><ArticleIdList><ArticleId IdType="pubmed">11931618</ArticleId></ArticleIdList></Reference><Reference><Citation>Lentz KN, et al. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: Comparison of the structural and biological properties of three poliovirus serotypes. Structure. 1997;5(7):961&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pubmed">9261087</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E, Rossmann MG. Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 &#xc5;. J Mol Biol. 1990;211(4):763&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">2156077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleywegt GJ, Br&#xfc;nger AT. Checking your imagination: Applications of the free R value. Structure. 1996;4(8):897&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">8805582</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, et al. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob Agents Chemother. 2004;48(9):3523&#x2013;3529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC514779</ArticleId><ArticleId IdType="pubmed">15328120</ArticleId></ArticleIdList></Reference><Reference><Citation>Badger J, Minor I, Oliveira MA, Smith TJ, Rossmann MG. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. Proteins. 1989;6(1):1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">2558377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield AT, Diana GD, Rossmann MG. Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16. Proc Natl Acad Sci USA. 1999;96(26):14730&#x2013;14735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24716</ArticleId><ArticleId IdType="pubmed">10611281</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. Structure determination of enterovirus 71. Acta Crystallogr D Biol Crystallogr. 2012;68(Pt 9):1217&#x2013;1222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3489104</ArticleId><ArticleId IdType="pubmed">22948923</ArticleId></ArticleIdList></Reference><Reference><Citation>Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">27754618</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L, Rossmann MG. Rotation function calculations with GLRF program. Methods Enzymol. 1997;276:594&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">9048382</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy AJ, et al. Phaser crystallographic software. J Appl Cryst. 2007;40(Pt 4):658&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2483472</ArticleId><ArticleId IdType="pubmed">19461840</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xfc;nger AT, et al. Crystallography &amp; NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. 1998;54(Pt 5):905&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pubmed">9757107</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleywegt GJ, Read RJ. Not your average density. Structure. 1997;5(12):1557&#x2013;1569.</Citation><ArticleIdList><ArticleId IdType="pubmed">9438862</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991;47(Pt 2):110&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">2025413</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborative Computational Project, Number 4 The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994;50(Pt 5):760&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">15299374</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandenburg B, et al. Imaging poliovirus entry in live cells. PLoS Biol. 2007;5(7):e183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1914398</ArticleId><ArticleId IdType="pubmed">17622193</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>